OTHER INFORMATION
+Added: On September 30, 2021, the Company delivered a notice of termination without cause to Seth Van Voorhees and removed him
+Added: from his position as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer.
+Added: The Company and Mr.
+Added: Van Voorhees are continuing to discuss the terms of Mr.
+Added: Van Voorhees separation from the Company.
EXHIBIT INDEX
Exhibit Description
−Removed: Amendment to Employment Agreement by and between PDS Biotechnology Corporation and Gregory Conn, Ph.D., effective as of June 17, 2021 (filed as Exhibit 10.2 to the Company’s Current
−Removed: Report on Form 8-K filed on June 21, 2021 and incorporated by reference herein).
−Removed: Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley
−Removed: Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley
+Added: Executive Employment Agreement, dated October 4, 2021, by and between PDS Biotechnology Corporation and Matthew Hill (filed as
+Added: Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 6, 2021, and incorporated by reference herein).
+Added: Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934,
+Added: as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934,
+Added: as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Principal Executive Officer Pursuant to 18 U.S.C.
−Removed: Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
+Added: Section 1350, as adopted pursuant to Section 906 of the
+Added: Sarbanes-Oxley Act of 2002 (furnished herewith).
Certification of Principal Financial Officer Pursuant to 18 U.S.C.
−Removed: Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
−Removed: Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
+Added: Section 1350, as adopted pursuant to Section 906 of the
+Added: Sarbanes-Oxley Act of 2002 (furnished herewith).
+Added: Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded
+Added: within the Inline XBRL document)
Inline XBRL Taxonomy Extension Schema Document
5 unchanged sentences
Filed herewith (unless otherwise noted as being furnished herewith)
−Removed: Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: Certain portions of the Exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K.
+Added: Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly
PDS Biotechnology Corporation
−Removed: August 12, 2021
+Added: November 10, 2021
/s/ Frank Bedu-Addo
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 12, 2021
−Removed: /s/ Seth Van Voorhees
−Removed: Seth Van Voorhees
+Added: November 10, 2021
+Added: /s/ Matthew Hill
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.